Explore the serious risks of long COVID and its potential impact on health. Can lingering symptoms from COVID-19 be fatal?

Nashville, Tennessee Friday, November 8, 2024, 13:00 Hrs [IST] ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that the United States (U.S.) Food and Drug Administration (FDA) granted Orphan Drug Designation and ...

Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...

With early intervention the disease is rarely fatal; however ... developing novel therapies for the treatment of orphan pulmonary and fibrosis indications, we are honored that they have chosen ...

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Insmed (INSM – Research Report), with a price ...

Double lung transplant recipient, Linda Paradis, is raising awareness of the importance of organ donation, as she now needs a kidney.

However these microbubbles dissolve rapidly in the blood and lose their echogenicity, and are unable to traverse the pulmonary microcirculation ... [7] The risks of both non-fatal myocardial ...

Hypophosphatasia is fatal in most patients and ... to pay at the German price level (AATC of €530,000). Cystic fibrosis and pulmonary arterial hypertension In cases where there are multiple ...

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.